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CHANGES IN SERUM INSULIN, BLOOD SUGAR, AND FREE FATTY ACID LEVELS
FOUR HOURS AFTER ADMINISTRATION OF HUMAN GROWTH HORMONE
TO FASTING CHILDREN WITH SHORT STATURE¶
Previous studies on normal and hypopituitary adults have demonstrated
that administration of human growth hormone (HGH) is associated with
changes in blood sugar (BS),'- free fatty acids (FFA),"4 insulin like
activity (ILA),' and plasma immunoreactive insulin (IRI).' The following
investigation was carried out to study the acute effects of HGH on serum
IRI, BS, and plasma FFA concentrations in normal and hypopituitary
children.
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NIATERIALS AND METHODS
A total of 17 children were studied. The clinical characteristics are summarized in
Table 1. Seven (Group I, ages 9-15 years-heights from the 25th to the 75th percen-
tile) were normal; five (Group II, ages 7-14 years-heights from the 1st to the 3rd
percentile) were "normal" but considered genetically short because of a positive
family history of short stature, a normal growth rate over the previous years and
a lack of demonstrable endocrinopathies; and five (Group III, ages 9-11 years-
heights significantly below the 1st percentile) had slow growth rates and deficiencies
of one or more anterior pituitary hormones. Each subject had an evaluation of his
CNS-pituitary function that included a protein-bound iodine, cholesterol, thyroidal I"
TABLE 1. CLINICAL CHARACTERISTICS OF NORMAL AND
SHORT STATURED SUBJECTS
Groups
Characteristics I II III
"Genetic"
Normtal short stature Idiopathic hypopit.
Number-total (male-female) 7 (5-2) 5 (4-1) 5 (4-1)
Age (yr.-mo.) mean 12-4 9-8 9-11
range 9-10 to 15-0 7-1 to 13-9 8-11 to 11-1
Stature (percentiles) 25-90 1-3 <1
Growth rates for age Normal Normal Abnormal
Endocrine abnormalities* None None Thyroid-4;
adrenal-3
* See MATERIALS and METHODS for an explanation of endocrine evaluation.
uptake, wrist X-rays for determination of skeletal maturation, response of urinary
17-hydroxycorticoids (17-OH) and 17 ketosteroids (17 KS) to ACTH and metyra-
pone, water load test, measure of response to insulin-induced hypoglycemia and
urinary gonadotropins. Those children whose heights were not below the 1st percentile
showed no evidence of endocrine dysfunction. In contrast, all five patients with
heights below the 1st percentile had one or more abnormalities: three had PBI
concentrations < 3.5 g.og%, four had 24 hour RAI uptakes of 15% or less, two had
skeletal maturations significantly more delayed than linear growth, three had abnormal
response to metyrapone, two had a poor urinary 17 OH steroid response to ACTH,
and two had an abnormal water load test corrected by cortisol. A slow linear
growth rate was present in all five. Four showed an abnormal response of either
BS or FFA to insulin-induced hypoglycemia. None showed any evidence of sexual
maturation but all were less than 11 1/12 years of age. All five had normal skull films.
Responsiveness to HGH was tested as follows: normally active and well subjects
eating a normal diet with a 9: 00 p.m. snack for 3 days were studied on the 4th day,
at which time blood samples were obtained at 5:00 and 9:00 a.m. (i.e., after 8 and
12 hours of fasting) for serum IRI, BS, and FFA. Four to seven days later, the
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same procedure was repeated, altered only by an IM injection of 2 mg. HGH immedi-
ately after the 8 hour fasting blood sample had been obtained.
Blood sugar was determined using the Somogyi-Nelson method7 and FFA
measured by the method of Dole.8 Serum insulin concentration was measured using
a double antibody radio-immunoassay.9 Statistical analysis was carried out using
the "Student's T" test.
RESULTS
Eight and 12 hour fasting IRI and BS concentrations were not signifi-
cantly different in any of the groups so the data are combined for comparing
TABLE 2. EFFECT OF FASTING AND HGH ON SERUM IRI AND BS IN
NORMAL AND SHORT STATURED CHILDREN
No. determi-
Groups** nations
A. IRI-microunits/ml.
I 21
II 14
III 15
B. FBS-mg/100 ml.
I 2
II
III 1!
Fasting (80 + 120)
Mean + S.E.M.
(range)
9.2±0.9 (2.5-15.0)
5.9±0.8 (3.0-12.0)
2.6±0.8 (0 -11.5)
1 81±1.3 (73-97)
3 78±+1.5 (71-88)
5 70±1.2 (63-79)
No. determi-
nations
Fasting (120)
+ HGH*
Mean + S.E.M.
(range)
7 10.5 ± 1.6 (2.5-14.0)
4 6.4+0.9 (5.0-9.0)
5 2.1±0.8 (0 -4.5)
7 76± 1.8 (73-86)
5 82±2.8 (74-88)
5 75±2.4 (65-80)
* 2 mg. giyen IM immediately after obtaining
** Group I-Normal
Group II-"Genetic" short stature
Group III-Idiopathic hypopituitarism.
8 hr. fasting sample.
differences between groups and within groups before and after HGH
(Table 2). Mean fasting IRI concentrations before and after HGH admin-
istration in the children with pituitary deficiencies (Group III) were
significantly lower (P < 0.01) than those of the normal children (Group I)
or children with genetic short stature (Group II). The mean fasting IRI
concentration of Group II was significantly less (P < 0.02) than that of
Group I without HGH. The same type of difference in serum IRI concen-
trations between Group I and II is apparent after HGH although the
number of subjects and the variability of the IRI values were such that
the differences observed were not significant. A single intramuscular
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injection of 2 mg. of HGH appears to have no effect on serum IRI
concentrations obtained four hours later in any of the groups.
The blood sugar concentrations of both Group I and Group II prior to
HGH were significantly greater than the mean BS concentration of Group
III (P < 0.01) but not significantly different from each other (Table 2).
Following the single IM injection of HGH there were no significant
differences among the three groups, since the mean BS concentration of
the children in Group III had increased. The number of BS determinations
on children in Group III after HGH, however, were not sufficient to
establish a significant effect of HGH on BS concentrations in this group
TABLE 3. EFFECT OF FASTING AND HGH ON PLAS;AMA FFA IN
NORMAL AND SHORT STATURED CHILDREN
No. HGH FFA--microeq./1--mean ± SE (range)
Group* Ind.t Amt.** 8 hr. fast 12 hr. fast 12 hr.-8 hr. (A)
I 7 0 467±124 (266-1177) 502± 52 (301-650) 31+109 (-541-350)
7 2mg. 355± 43 (241-586) 780± 30 (447-1176) 424± 99 (158-882)
14 0 411± 65 (266-1177)
II 5 0 676± 74 (287-1137) 1074±205 (686-1811) 397+189 (-31-1097)
5 2mg. 444+ 70 (241-661) 1170± 35 (866-1416) 725± 80 (474-892)
10 0 560± 86 (241-1137)
III 4 0 554± 81 (366-714) 1001+138 (610-1327) 398+144 (204-664)
5 2mg. 741± 93 (510-1058) 1555± 23 (1347-1784) 804±133 (289-1026)
9 0 658± 65 (366-1058)
*Group I-Normal
Group II-"Genetic" short stature
Group III-Idiopathic hypopituitarism.
** 2 mg. given IM immediately after obtaining 8 hr. fasting sample.
t No. Ind. = Number of Individuals.
The mean 8 hour fasting FFA concentration of the children in Group III
(658 + 65 p.Eq/L) was significantly greater (P < 0.02) than that of the
normal children (411 + 65 uEq/L) although the range of values overlaps
in all groups (Table 3). Again, the children with genetic short stature have
a mean 8 hour fasting value intermediated between, but not significantly
different from Groups I and III (560 + 86 liEqc/L). The mean 12 hour
fasting FFA concentrations of both the genetic and pituitary deficient short
stature groups, however, are significantly different (P < 0.01) from the
normal group with alnmost no overlap in the range of values. The large
significant error of the mean (SEM) values for the 12 houir fasting con-
centration of FFA in both groups of short statured children is striking,
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especially when compared to the values for the same group four hours
after a single IM injection of 2 mg. of HGH. These findings suggest that
both the genetic and pituitary-deficient short statured child are more
susceptible than normal children to the stimulus of prolonged fasting, with
respect to factors that mobilize FFA. All three groups of children showed
a similar effect of HGH on mobilization of FFA by a greater than twofold
increase with a marked decrease in standard errors of the mean. Thus the
HGH administered appeared to be biologically active in all groups of
subjects studied.
DISCUSSION
The present study has demonstrated significantly lower concentrations
of serum IRI in fasting children with pituitary dysfunction and confirms
the studies of others on hypopituitary adults.Y" Furthermore, these hypo-
pituitary children show significantly lower 8 and 12 hour fasting BS
concentrations and greater FFA concentrations than do normal children,
including those with short stature. One of the explanations for these
findings is that the hypopituitary children adapt more quickly to the fasted
state than do normal children.' Luft, et al.' in studying three hypopituitary
patients, demonstrated an apparent significant rise in FBS, serum IRI and
plasma FFA afer HGH injections (10 mg. 2 times/day) for four days.
In addition, long-term (5-10 days, 10 mg/d) HGH administration has
been accompanied by deterioration in carbohydrate tolerance, and eleva-
tions in FBS and serum IRI. Similar observations of augmentation of
growth hormone after insulin secretion in dogs have been reported.'"
However, Kipnis and Stein" found no significant change in either blood
glucose or serum IRI during a five hour intravenous infusion of HGH to
normal adults or to adults with hypopituitarism, although a significant
rise of plasma FFA was seen in both groups. The responses of the children
in this study given one intramuscular injection of 2 mg. of HGH were
similar to those reported by the latter group.
Since changes in serum IRI concentrations have not been observed after
single IM injections or five hour intravenous infusions, the effect of HGH
on IRI secretion in zvivo must not be directly on pancreatic islet cell tissue.
The children with genetic short stature who were studied come from
families in which there were many other short individuals. Their heights
were within two standard deviations of the average for age and they were
growing at a normal rate. In addition, they had no clinical or laboratory
evidence of endocrine dysfunction. For these reasons, the observed signifi-
cant differences in fasting serum IRI and FFA concentrations between this
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group and the children with normal stature were unexpected. These
differences cannot be completely explained, since sufficient data on a normal
group of children of the same age and degree of development are not avail-
able. However, previously reported studies1" from our laboratories have
shown that children from 3 to 9 years of age have fasting serum IRI con-
centrations significantly lower than infants up to 2 years, adolescents 10-16
years, and adults. Since two of the children in Group II were 7 years of
age, it seems possible that the lowered mean IRI concentration in Group
II may be attributed, in part, to the fact that the children were younger
than those in Group I. The fact that the changes in IRI and FFA are in
the same direction as those found in the children with hypopituitarism, al-
though less marked, raises the possibility that the subjects included in
Group II may have an alteration in HGH metabolism (synthesis, release,
tissue response, etc.). The likelihood that there is a genetic determinant for
this possible metabolic alteration warrants additional study.
SUMMARY
Serum immunoreactive insulin (IRI), fasting blood sugars (FBS), and
free fatty acids (FFA) were obtained on two days after fast periods of 8
and 12 hours from seven normal children (Group I, ages 9-15 years-
heights, above the 25th percentile), five genetically short children (Group
II, ages 7-14 years-heights between the 1st and 3rd percentile) and
five children with idiopathic hypopituitarism (Group III, ages 9-11 years-
heights significantly below the 1st percentile). On the second day, 4 to 7
days after the first study, two milligrams of human growth hormone
(HGH) were administered intramuscularly after obtaining the 8 hour blood
sample. Within each group mean serum IRI values after 8 and 12 hour
periods of fast were not significantly different. Mean IRI values in the
children in Group I were 9.2 microunits/ml., in Group II, 5.9 micro-
units/ml., and in Group III, 2.3 microunits/mil., the IRI concentrations
in the hypopituitary children being significantly lower (P < 0.01) than in
the other two groups. Four hours after HGH, mean IRI concentrations
wvere not significantly increased in any of the groups. Mlean FBS values at
8 hours in the hypopituitary group were lower than the other two groups
b)ut were not significantly increased in any group after HGH. Mean 8 and
12 hour fasting FFA in the hypopituitary subjects and mean 12 hour fasting
FFA in the genetically short subjects were significantly greater than those
in the normal subjects. All three groups showed the expected increases (two
to threefold) in FFA after HGH.
These results show that children with hypopituitarism have lower fast-
ing concentrations of IRI and blood sugar but higher and more variable
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concentrations of FFA. A single IM injection of HGH, capable of in-
creasing plasma FFA in normal as well as hypopituitary subjects, did not
increase serum IRI or blood sugar concentrations significantly in any of
the subjects. An unexpected finding was that mean fasting IRI levels were
significantly lower in genetically short children as compared with controls.
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